The aim of the Biomedical Catalyst is to support the development of innovative healthcare products, technologies and processes. These can include (but are not limited to):
This competition closes at midday 12pm UK time on the deadline stated.
The Biomedical Catalyst has 4 funding strands to support the progression of projects from initial concept through to late stage development:
This competition combines the early and late stage strands.
A separate competition combining the feasibility and primer strands is being run in conjunction with this one. You can apply for this early and late stage competition without needing to go through feasibility and primer.
The aim of this competition is to enable companies to create a data package that can support the subsequent testing of your products or carry out evaluations in a clinical setting or another relevant environment. This can include:
Your project must focus on the development of a product or process that is an innovative solution to a health and care challenge.
This competition has 2 stages.
Stage 1: assessed written application.
Stage 2: interview with our Major Awards Committee (MAC).
Be aware that your project may be subject to interim reviews at important decision points.
Any UK business claiming funding must be eligible to receive state aid at the time Innovate UK confirm you will be awarded funding. If you are unsure please take legal advice. For further information see their general guidance.
Your project must start by 1 September 2019 and end by 31 March 2021. It can last between 3 and 18 months.
If your project’s total eligible costs or duration fall outside of Innovate UK's eligibility criteria, you must provide justification by email to email@example.com at least 10 days before the competition closes. They will decide whether to approve your request.
To lead a project or work alone you must:
You can work alone or in partnership with others (SMEs, academics or research organisations).
If your project is academic-led you need to apply to the Medical Research Council instead.
Support is available for any life science sector or discipline, including (but not limited to):
If you choose the innovation area ‘Diagnostics, medical technology and devices’, you must indicate in the initial project summary whether your project falls within ‘Diagnostics’ or ‘Medical technology and devices’.
Innovate UK will fund feasibility studies and industrial research projects. Please see the general guidance to help you decide which category your project fits in.
Innovate UK will not fund projects as part of this competition that are in scope for the Biomedical Catalyst feasibility or primer awards.
Learn more about the feasibility or primer awards